非霍奇金淋巴瘤患者血清中MMP-9和MMP-2蛋白的检测及临床意义
出处
《中华检验医学杂志》
CAS
CSCD
北大核心
2006年第3期242-243,共2页
Chinese Journal of Laboratory Medicine
参考文献8
-
1Roebuck MM,Helliwell TR,Chaudhry IH,et al.Matrix metalloproteinase expression is related to angiogenesis and histologic grade in spindle cell soft tissue neoplasms of the extremities.Am J Clin Pathol,2005,123:405-414.
-
2Kugler A.Matrix metalloproteinases and their inhibitors.Anticancer Res,1999,19:1589-1592.
-
3陈龙邦,李桂圆,王靖华,周晓军,马恒辉,徐炜.VEGF、MMP-2在非小细胞肺癌中的表达及其与肿瘤血管形成的关系[J].医学研究生学报,2002,15(6):482-484. 被引量:7
-
4Lowry OH,Rose-brough NJ,Farr AL,et al.Protein measurement with folin phenol reagent.J Biol Chem,1951,193:265-275.
-
5Kleiner DE,Stetler Stevenson WG.Quantiative zymographyodetection pictogram quantities of Gelatinase.Anal Biochem,1994,218:325-329.
-
6刘煜,张嘉宁,朱正美.基质金属蛋白酶酶谱分析法[J].生殖医学杂志,1998,7(2):111-113. 被引量:16
-
7Papathoma AS,Petraki C,Grigorakis A,et al.Prognostic significance of matrix metalloprotein -ases 2 and 9 in bladder cancer.Anticancer Res,2000,20:2009-2013.
-
8Zucker S,Lysik RM,Zarrabi HM.Plasma assay of matrix metalloproteinases and MMP-inhibitor complexes in cancer,Potential use in predicting metastasis and monitoring treatment.Ann NY A cad Sci,1994,732:248-252.
二级参考文献8
-
1Chamber AF,Matrisian LM.Changing views of matrix metalloproteinase in metastasis[J].J Natl Cancer Inst,1997,89:1260-1265.
-
2Weiderner N. Intratumor nicrovessel density as a prognostic factor in cancer [J].Am J Pathal,1995;147:9-19
-
3Walkui S,Furusato M, Itoh T, et al. Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study[J]. J Pathol, 1992,168:257-262.
-
4Weiderner N. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow [J].J pathol,1998,184:119-122.
-
5Person SL,Watson SA,Brown PD,et al. Matrix metalloproteinases[J]. Br J Surg,1997,84:160-166.
-
6Person SL,Watson SA,Collins HM,et al.Gelatinase(MMP-2 and MMP-9) ecpressio in gastrointestinal malignancy[J].Br J Comcer,1998,78(11):1495-1502.
-
7Lamper K,Machein U,Machein MR,et al. Expression of matrix metalloproteinasesand their tissue inhibitors in human brain tumors[J].Am Jpathol,1998,153:429-432.
-
8Zeng ZS, CohenAM,GuillemJG. Loss of basement membrane type Ⅳ collagen is associated with increased expression of metalloprotemases 2 and 9(MMP-2 and MMP-9) during human colorectal tumorigenesis [J].Carcingenesis, 1999,20(5):749-745.
共引文献21
-
1李黎 ,吴苏稼 .内源性肿瘤血管生成抑制物的研究进展[J].医学研究生学报,2004,17(6):542-545. 被引量:2
-
2陈宇,田鲲,耿宁,杨名仲,章卫平.基质金属蛋白酶及其组织抑制剂在涎腺多形性腺瘤生物学行为中的意义[J].中华口腔医学杂志,2005,40(1):58-61. 被引量:7
-
3张红梅,王唯红,徐文方.一种筛选明胶酶抑制剂的微量分析方法[J].药物分析杂志,2005,25(5):547-549. 被引量:1
-
4田鲲,陈宇,耿宁,杨名仲,章卫平.基质金属蛋白酶及其组织抑制剂表达失衡与涎腺恶性肿瘤浸润生长的关系[J].华西口腔医学杂志,2005,23(4):273-276. 被引量:10
-
5刘海英,关咏梅,傅松滨.基质金属蛋白酶及其抑制剂在子宫内膜异位症中的研究进展[J].国外医学(遗传学分册),2005,28(4):232-235. 被引量:1
-
6卓文磊,王彦,陈正堂,敖绪军.透明质酸诱导人肺腺癌A549细胞表达血管内皮生长因子-C[J].医学研究生学报,2007,20(2):128-131. 被引量:2
-
7谢斌,董家鸿.逆转录病毒介导的c-met-小干扰RNA抑制肝癌转移的体内研究[J].中华肝脏病杂志,2007,15(5):391-392. 被引量:4
-
8刁瑞英,宋良文,王少霞,李明.^(60)Coγ射线照射对肺泡Ⅱ型细胞和肺泡隔间质细胞的生物效应[J].细胞与分子免疫学杂志,2008,24(2):119-121. 被引量:1
-
9韦素华,徐文,姜玉珍,罗曼宇.基质金属蛋白酶MMP-2及MMP-9在淋巴系肿瘤中的表达[J].中国生物制品学杂志,2008,21(4):292-294. 被引量:1
-
10田鲲,彭敏,陈宇,耿宁.免疫组化、明胶酶谱、Western Blot检测涎腺肿瘤中基质金属蛋白酶MMP-2、MMP-9表达的比较与评价[J].实用医院临床杂志,2010,7(5):17-21. 被引量:10
-
1姜志钢,鄂征.不同肿瘤组织和细胞促血管生成活性研究[J].中华肿瘤杂志,1989,11(3):165-167. 被引量:4
-
2陈玉清,李琳,张茵,臧玉柱,郭建民.香菇多糖联合CHOP方案治疗非霍奇金淋巴瘤[J].医药论坛杂志,2005,26(11):48-49. 被引量:6
-
3刘玉荣,王凯,张慧玲.CHOP方案治疗侵袭性非霍奇金淋巴瘤患者的观察及护理[J].中国现代药物应用,2009,3(1):155-156. 被引量:1
-
4汤虎成,曾慧.利妥昔单抗联合CHOP方案治疗非霍奇金淋巴瘤的效果观察[J].中国当代医药,2014,21(26):101-102. 被引量:6
-
5杨君.以腹水为首发表现的非霍奇金淋巴瘤1例报告[J].长江大学学报(自科版)(下旬),2012,8(4):27-28.
-
6王洋.利妥昔单抗联合CHOP方案治疗39例非霍奇金淋巴瘤疗效分析[J].中国伤残医学,2014,22(19):125-126.
-
7杨序春,杨文西,方国安,金秀国,膝漕华.非霍奇金淋巴瘤患者T细胞亚群测定的临床意义初探[J].临床荟萃,1999,14(24):1124-1125.
-
8刘丹.非霍奇金淋巴瘤采用美罗华联合CHOP方案治疗的临床观察[J].大家健康(学术版),2014(22):149-149.
-
9刘丽云.利妥昔单抗联合化疗治疗非霍奇金淋巴瘤6例临床护理[J].齐鲁护理杂志,2008,14(6):100-100.
-
10陈国俊,王健.MMP-2和MMP-9在膀胱癌组织中的表达及相关性研究[J].陕西医学杂志,2007,36(1):41-44. 被引量:3